11A
DBD

10-15 Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

10-15 Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-89,139
Closed -$998K – 104
2019
Q3 		$998K Sell
89,139
-1,587
-2% -$18.8K 0.21% 68
2019
Q2 		$831K Sell
90,726
-523
-0.6% -$5.46K 0.18% 72
2019
Q1 		$1.01M Sell
91,249
-3,678
-4% -$25.7K 0.22% 68
2018
Q4 		$236K Sell
94,927
-13,281
-12% -$47.6K 0.06% 84
2018
Q3 		$487K Sell
108,208
-1,765
-2% -$12.9K 0.11% 81
2018
Q2 		$1.31M Buy
109,973
+2,410
+2% +$32.3K 0.3% 66
2018
Q1 		$1.66M Buy
107,563
+9,425
+10% +$157K 0.39% 57
2017
Q4 		$1.6M Buy
98,138
+505
+0.5% +$9.76K 0.38% 56
2017
Q3 		$2.23M Buy
97,633
+33,536
+52% +$715K 0.56% 47
2017
Q2 		$1.79M Buy
64,097
+2,575
+4% +$71.2K 0.5% 47
2017
Q1 		$1.89M Buy
61,522
+660
+1% +$18.6K 0.52% 49
2016
Q4 		$1.53M Buy
+60,862
New +$1.44M 0.43% 58

Other funds holding DBD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

10-15 Associates's DBD Position: Q4 2019 in Review

10-15 Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2019, closing a stake of 89,139 shares — an estimated $998K sold.

10-15 Associates first reported a position in DBD in Q4 2016 and held it in 12 quarters. The position peaked at $2.23M in Q3 2017. 199 funds tracked by Wall St. Rank hold DBD as of Q4 2019.

  • 10-15 Associates reported no remaining Diebold Nixdorf Incorporated position as of Q4 2019 after selling out during the quarter.
  • 10-15 Associates sold 89,139 Diebold Nixdorf Incorporated shares in Q4 2019, an estimated $998K.
  • 10-15 Associates first reported a position in Diebold Nixdorf Incorporated in Q4 2016 and held it in 12 quarters.
  • 10-15 Associates's Diebold Nixdorf Incorporated position peaked at $2.23M in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2019.

Based on 10-15 Associates's 13F filing for Q4 2019, filed 24 Jan 2020.